1 |
DEFESCHE J C, GIDDING S S, HARADA-SHIBA M,et al. Familial hypercholesterolaemia[J]. Nat Rev Dis Primers, 2017, 3: 17093.
|
2 |
GARG A, GARG V, HEGELE R A, et al. Practical definitions of severe versus familial hypercholesterolaemia and hypertriglyceridaemia for adult clinical practice[J]. Lancet Diabetes Endocrinol, 2019, 7(11): 880-886.
|
3 |
HANSSON G K, ZHOU X, TÖRNQUIST E, et al. The role of adaptive immunity in atherosclerosis [J]. Ann N Y Acad Sci, 2000, 902: 53-62; discussion 62-64.
|
4 |
HOVINGH G K, DAVIDSON M H, KASTELEIN J J P, et al. Diagnosis and treatment of familial hypercholesterolaemia[J]. Eur Heart J, 2013, 34(13): 962-971.
|
5 |
FROSTEGÅRD J. Immunity, atherosclerosis and cardiovascular disease[J]. BMC Med, 2013, 11: 117.
|
6 |
AMMIRATI E, CIANFLONE D, VECCHIO V,et al. Effector memory T cells are associated with atherosclerosis in humans and animal models[J]. J Am Heart Assoc, 2012, 1(1): 27-41.
|
7 |
SCHULTE S, SUKHOVA G K, LIBBY P. Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis[J]. Am J Pathol, 2008, 172(6): 1500-1508.
|
8 |
TAGHIZADEH E, TAHERI F, GHEIBI HAYAT S M, et al. The atherogenic role of immune cells in familial hypercholesterolemia[J]. IUBMB Life, 2020, 72(4): 782-789.
|
9 |
PROTO J D, DORAN A C, SUBRAMANIAN M,et al.Hypercholesterolemia induces T cell expansion in humanized immune mice[J].J Clin Invest,2018,128(6): 2370-2375.
|
10 |
LAN P, TONOMURA N, SHIMIZU A, et al. Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation[J]. Blood, 2006, 108(2): 487-492.
|
11 |
TONOMURA N, HABIRO K, SHIMIZU A, et al. Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model[J]. Blood, 2008, 111(8): 4293-4296.
|
12 |
GO G W, MANI A. Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis[J]. Yale J Biol Med, 2012, 85(1): 19-28.
|
13 |
BIETZ A, ZHU H Y, XUE M M, et al. Cholesterol metabolism in T cells[J]. Front Immunol, 2017, 8: 1664.
|
14 |
MAILER R K W, GISTERÅ A, POLYZOS K A,et al. Hypercholesterolemia induces differentiation of regulatory T cells in the liver[J]. Circ Res, 2017, 120(11): 1740-1753.
|
15 |
YANG W, BAI Y B, XIONG Y, et al. Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism[J]. Nature, 2016, 531(7596): 651-655.
|
16 |
ARMSTRONG A J, GEBRE A K, PARKS J S, et al. ATP-binding cassette transporter G1 negatively regulates thymocyte and peripheral lymphocyte proliferation[J]. J Immunol, 2010, 184(1): 173-183.
|
17 |
WINKELS H, EHINGER E, VASSALLO M, et al. Atlas of the immune cell repertoire in mouse atherosclerosis defined by single-cell RNA-sequencing and mass cytometry[J]. Circ Res, 2018, 122(12): 1675-1688.
|
18 |
MENDEZ-FERNANDEZ Y V, STEVENSON B G, DIEHL C J, et al. The inhibitory FcγRIIb modulates the inflammatory response and influences atherosclerosis in male apoE (-/-) mice[J]. Atherosclerosis, 2011, 214(1): 73-80.
|
19 |
HONG S, ZHANG Z M, LIU H T, et al. B cells are the dominant antigen-presenting cells that activate naive CD4 + T cells upon immunization with a virus-derived nanoparticle antigen[J]. Immunity, 2018, 49(4): 695-708.e4.
|
20 |
MAILER R K W, GISTERÅ A, POLYZOS K A, et al. Hypercholesterolemia induces differentiation of regulatory T cells in the liver[J]. Circ Res, 2017, 120(11): 1740-1753.
|
21 |
GETZ G S, REARDON C A. Animal models of atherosclerosis [J]. Arterioscler Thromb Vasc Biol, 2012, 32(5): 1104-1115.
|
22 |
陈 冰, 刘昊川, 李龙云, 等. 人源化小鼠模型构建和应用的研究进展 [J]. 吉林大学学报(医学版), 2018, 44(3): 667-674.
|
23 |
杨炜峰,苗振川,宋希军,等.HBV感染的动物模型研究进展[J].临床肝胆病杂志,2021,37(5):999-1005.
|